• 1
    Salles G, Shipp MA, Coiffier B. Chemotherapy of non-Hodgkin's aggressive lymphomas. Semin Hematol 1994; 31: 4669.
  • 2
    Armitage JO. Treatment of non-Hodgkin's lymphoma. N. Engl J Med 1993; 328: 10231030.
  • 3
    Weeks JC, Yeap BY, Canellos GP, Shipp MA. Value of follow-up procedures in patients with large-cell lymphoma who achieve complete remission. J Clin Oncol 1991; 9: 11961203.
  • 4
    Edelman MJ, Meyers FJ, Siegel D. The utility of follow-up testing after curative cancer therapy. A critical review and economic analysis. J Gen Intern Med 1997; 12: 318331.
  • 5
    National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage. Cancer 1982; 49: 21122135.
  • 6
    The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329: 987994.
  • 7
    Connors JM. The cured lymphoma patient. Guidelines for long term follow-up. Postgrad Med 1982; 72: 5359.
  • 8
    Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-Lopez A, Hagenbeek A, Cabanillas F, Klippensten D, Hiddemann W, Castellino R, Harris NL, Armitage JO, Carter W, Hoppe R, Canellos GP. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. J Clin Oncol 1999; 17: 12441253.
  • 9
    Shipp MA, Klatt MM, Yeap B, Jochelson MS, Mauch PM, Rosenthal DS, Skarin AT, Canellos GP. Patterns of relapse in large-cell lymphoma patients with bulk disease: implications for the use of adjuvant radiation theraphy. J Clin Oncol 1989; 7: 613618.
  • 10
    Weiss M, Loprizini CL, Creagon ET. Utility of follow-up tests for detecting disease recurrence of surgically resected primary malignant melanoma. Proc Am Soc Clin Oncol 1995; 14: 307 (Abstract 893).
  • 11
    Zwaveling A, Albers GHR, Felthuis W, Hermans J. An evaluation of routine follow-up for detection of breast cancer recurrences. J Surg Oncol 1987; 34: 194197.
  • 12
    Hortobagyi GN. Treatment of breast cancer. N Engl J Med 1998; 339: 974984.
  • 13
    The Givio Investigators. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. J Am Med Assoc 1994; 271: 15871592.
  • 14
    Rosselli Del Turco M, Palli D, Cariddi A, Ciatto S, Pacini P, Distante V. Intensive diagnostic follow-up after treatment of primary breast cancer. J Am Med Assoc 1994; 271: 15931597.
  • 15
    Berchuck A, Auspach C, Evans AC, Soper JT, Rodriguez GC, Dodge R, Robboy S, Clarke-Pearson DL. Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma. Gynecol Oncol 1995; 59: 2024.
  • 16
    Reddoch JM, Burke TW, Morris M, Tornos C, Levenbock C, Gershenson DM. Surveillance for recurrent endometrial carcinoma: development of a follow-up scheme. Gynecol Oncol 1995; 59: 221225.
  • 17
    Radford JA, Eardley A, Woodman C. Routine out-patient review following treatment for Hodgkin's disease: is it an efficient way for detecting relapse? Proc Am Soc Clin Oncol 1995; 14: 386 (Abstract 1201).
  • 18
    Torrey MJ, Poen JC, Hoppe RT. Detection of relapse in early-stage Hodgkin's disease: role of routine follow-up studies. J Clin Oncol 1997; 15: 11231130.